Company Valuation: AB Science

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 332.2 180.9 57.55 112 57.61 - -
Change - -45.55% -68.19% 94.7% -48.58% - -
Enterprise Value (EV) 332.2 180.9 57.55 112 57.61 57.61 57.61
Change - -45.55% -68.19% 94.7% -48.58% 0% 0%
P/E -24.4x -17.8x -5.88x - - - -
PBR - - - - - - -
PEG - 0.6x 0.2x - - - -
Capitalization / Revenue - 187x 53.7x 95.4x 48x 44.3x 36x
EV / Revenue - 0x 0x 0x 48x 44.3x 36x
EV / EBITDA - - - - - - -
EV / EBIT - -0x -0x 0x -8.86x -9x -
EV / FCF - -0x - -0x -9x -16x -14.8x
FCF Yield - -9.52% - -4.08% -11.1% -6.25% -6.77%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.29 -0.2 -0.15 - - - -
Distribution rate - - - - - - -
Net sales 1 - 0.97 1.072 1.174 1.2 1.3 1.6
EBITDA - -11.16 -5.416 - - - -
EBIT 1 - -13.43 -6.083 0.639 -6.5 -6.4 -
Net income -13.62 -10.05 -7.831 - - - -
Net Debt - - - - - - -
Reference price 2 7.0900 3.5550 0.8820 1.5360 0.7200 0.7200 0.7200
Nbr of stocks (in thousands) 46,861 50,891 65,248 72,947 80,015 - -
Announcement Date 01/03/23 15/05/24 13/05/25 13/05/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 67.51M
81.01x5.45x23.31x2.56% 328B
23.96x3.21x11.28x1.68% 70.25B
14.12x6.96x10.67x - 11.55B
16.77x2.13x7.22x2.7% 8.52B
20.73x6.56x17.46x-.--% 4.88B
41.73x2.61x29.84x0.68% 4.37B
36.15x6.82x19.51x - 4.22B
-239.35x - - -.--% 2.78B
Average -0.61x 4.82x 17.04x 1.27% 48.29B
Weighted average by Cap. 65.19x 5.06x 20.66x 2.35%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. AB Stock
  4. Valuation AB Science